Skip to content
healthcare.dev

Lynparza

NDC 0310-0668, olaparib, tablet, film coated, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-0668
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208558
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0668 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLAPARIB100 mg/1

Pharmacologic classes

Poly(ADP-Ribose) Polymerase Inhibitor [EPC]; Poly(ADP-Ribose) Polymerase Inhibitors [MoA]

Package NDCNDC-11Package
0310-0668-1200310066812120 TABLET, FILM COATED in 1 BOTTLE (0310-0668-12)
0310-0668-600031006686060 TABLET, FILM COATED in 1 BOTTLE (0310-0668-60)
0310-0668-950031006689560 TABLET, FILM COATED in 1 BOTTLE (0310-0668-95)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/741ff3e3-dc1a-45a6-84e5-2481b27131aa

Use it

Look up 0310-0668 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0668 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-0668. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.